fda status bpc 157 tb 500 Half of people taking research-grade peptides think they're FDA-approved. They're not. Ahead of a July meeting, a new Hone survey found 50% believe their peptides are already approved. The popular ones — FDA Peptide Panel: Members Sell
Description
TB-500 is the synthetic version of the naturally occurring Thymosin Beta-4 peptide

Although the exact mechanism of how BPC-157 works is not fully understood, it is believed to activate the body's healing mechanisms, stimulate cell growth, and promote blood vessel growth
Already have recent labs

A serum B12 level wouldn't help, and wastes everyone's time

Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
